Veterinary Medicines

LODEVIL

Authorised
  • Glucose
  • Magnesium chloride
  • Potassium chloride
  • Sodium chloride
  • Sodium hydrogen carbonate
  • Sodium acetate
Download as PDF

Product identification

Medicine name:
LODEVIL
Active substance:
  • Glucose
  • Magnesium chloride
  • Potassium chloride
  • Sodium chloride
  • Sodium hydrogen carbonate
  • Sodium acetate
Target species:
  • Cattle (calf)
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Glucose
    10.80
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride
    0.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium chloride
    0.45
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium chloride
    3.51
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium hydrogen carbonate
    4.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium acetate
    4.08
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle (calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/3830006 4/1982
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."